Table 2.
Characteristics of studies included in this systematic review.
| Author | Year | Sample size |
Mean age (year) (median/range) |
% men | Chemotherapy | Radix Astragali intervention | Control |
|---|---|---|---|---|---|---|---|
| Cui et al. [5] | 2009 | 40 | 60 | 57.5 | FOLFOX | Single herb extract | No intervention |
| Feng [6] | 2011 | 40 | 28～55 | 67.5 | FOLFOX | Compound prescription | No intervention |
| Huang et al. [7] | 2013 | 61 | 62.3 | 62.3 | FOLFOX | Compound prescription | No intervention |
| Huang et al. [8] | 2010 | 60 | 46 | 71.7 | FOLFOX | Compound prescription | No intervention |
| Jin et al. [9] | 2015 | 77 | 47.2 | 48.1 | FOLFOX | Compound prescription | No intervention |
| Kong [10] | 2012 | 40 | 40～60 | 52.5 | OXAL | Compound prescription | No intervention |
| Li et al. [11] | 2013 | 60 | 50.1 | 31.7 | FOLFOX | Compound prescription | GSH |
| Liang et al. [12] | 2012 | 84 | 32～73 | 70.2 | FOLFOX | Compound prescription | No intervention |
| Liang et al. [13] | 2015 | 135 | 47.8 | 67.4 | FOLFOX | Compound prescription | No intervention |
| Lin and Luo [14] | 2011 | 90 | 51 | 54.4 | FOLFOX | Compound prescription | No intervention |
| Liu et al. [15] | 2011 | 60 | 61.5 | 64.3 | FOLFOX, OXAL | Compound prescription | Mecobalamin |
| Liu [16] | 2009 | 68 | 31～70 | 60.3 | FOLFOX | Compound prescription | No intervention |
| Lv [17] | 2015 | 90 | 53.0 | 53.3 | OXAL | Compound prescription | Mecobalamin |
| Qin and Sun [18] | 2015 | 42 | 55 | 61.9 | FOLFOX | Compound prescription | Mecobalamin |
| Qin et al. [19] | 2012 | 68 | 57.2 | 47.1 | OXAL, TAX | Compound prescription | Cobamamide |
| Shen et al. [20] | 2015 | 60 | 59.7 | 65.0 | OXAL | Compound prescription | Mecobalamin |
| Sun et al. [21] | 2010 | 60 | 55.3 | 63.3 | FOLFOX, XELOX, TAX + 5-Fu | Compound prescription | Mecobalamin |
| Tan and Qi [22] | 2015 | 63 | 31～70 | 60.3 | OXAL | Compound prescription | Mecobalamin |
| Wang [23] | 2015 | 60 | 52.3 | 50.0 | FOLFOX | Compound prescription | Ca/Mg infusions |
| Wu et al. [24] | 2015 | 89 | 49.2 | 70.8 | Platinum, TAX, | Compound prescription | No intervention |
| Wu et al. [25] | 2012 | 60 | 23～71 | 65.8 | FOLFOX | Compound prescription | No intervention |
| Wu et al. [26] | 2015 | 60 | 59.7 | 65.6 | Platinum, TAX, VCR | Compound prescription | No intervention |
| Xu et al. [27] | 2011 | 40 | ∗ | 45.0 | OXAL | Compound prescription | No intervention |
| Zhang and Lu [28] | 2013 | 70 | 31–77 | 65.7 | FOLFOX | Single herb extract + thioctic acid |
No intervention |
FOLFOX: oxaliplatin + 5-fluorouracil + calcium folinate.
5-Fu: 5-fluorouracil.
GSH: glutathione.
OXAL: oxaliplatin.
TAX: taxol.
VCR: vincristine.
XELOX: oxaliplatin + capecitabine.